Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.
The vaccinia virus (VACV) strain Western Reserve C16 protein has been characterized and its effects on virus replication and virulence have been determined. The C16L gene is present in the inverted terminal repeat and so is one of the few VACV genes that are diploid. The C16 protein is highly conserved between different VACV strains, and also in the orthopoxviruses variola virus, ectromelia virus, horsepox virus and cowpox virus. C16 is a 37.5 kDa protein, which is expressed early during infection and localizes to the cell nucleus and cytoplasm of infected and transfected cells. The loss of the C16L gene had no effect on virus growth kinetics but did reduce plaque size slightly. Furthermore, the virulence of a virus lacking C16L (vDeltaC16) was reduced in a murine intranasal model compared with control viruses and there were reduced virus titres from 4 days post-infection. In the absence of C16, the recruitment of inflammatory cells in the lung and bronchoalveolar lavage was increased early after infection (day 3) and more CD4(+) and CD8(+) T cells expressed the CD69 activation marker. Conversely, late after infection with vDeltaC16 (day 10) there were fewer T cells remaining, indicating more rapid clearance of infection. Collectively, these data indicate that C16 diminishes the immune response and is an intracellular immunomodulator.
Fahy
Aodhnait S
AS
Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
Clark
Richard H
RH
Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
Glyde
Emily F
EF
Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
Smith
Geoffrey L
GL
Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
D000281:Administration, Intranasal; D000818:Animals; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D017353:Gene Deletion; D005786:Gene Expression Regulation; D006367:HeLa Cells; D054884:Host-Pathogen Interactions; D006801:Humans; D007271:Injections, Intradermal; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D014615:Vaccinia / Q000276:immunology* / Q000503:physiopathology / Q000821:virology; D014616:Vaccinia virus / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism*; D014774:Virulence
D008565:Membrane Proteins; D014759:Viral Envelope Proteins; C084759:p37 protein, Vaccinia virus
PLoS Pathog. 2008 Feb 8;4(2):e22
18266467
Cell. 1992 Oct 2;71(1):153-67
1394428
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10162-7
10920188
J Gen Virol. 2000 May;81(Pt 5):1223-30
10769064
J Gen Virol. 2002 Nov;83(Pt 11):2833-2844
12388820
Proc Natl Acad Sci U S A. 1983 Sep;80(17):5364-8
6310573
J Virol. 2005 Jan;79(2):966-77
15613325
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4825-9
1350676
Acta Biochim Pol. 2004;51(1):57-66
15094825
Parasitology. 2005;130 Suppl:S11-25
16281988
J Gen Virol. 1997 Mar;78 ( Pt 3):677-85
9049422
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2140-5
18245380
J Virol. 2003 Sep;77(18):9960-8
12941906
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11029-34
8855303
J Gen Virol. 1999 Oct;80 ( Pt 10):2751-2755
10573171
J Immunol. 1995 Nov 1;155(9):4467-75
7594609
J Gen Virol. 2002 Aug;83(Pt 8):1965-1976
12124460
Virology. 1988 May;164(1):182-92
3363864
J Gen Virol. 2001 Sep;82(Pt 9):2095-2105
11514718
J Gen Virol. 2006 Jun;87(Pt 6):1451-1458
16690909
J Gen Virol. 1990 Nov;71 ( Pt 11):2761-7
2254756
Virology. 1990 Nov;179(1):247-66, 517-63
2219722
J Virol. 1991 Jul;65(7):3598-606
2041086
PLoS Pathog. 2008 Aug 15;4(8):e1000128
18704168
Gene. 1988 May 15;65(1):123-8
2840353
J Immunol. 1998 Aug 15;161(4):2004-10
9712073
Annu Rev Microbiol. 2003;57:323-42
14527282
J Gen Virol. 2004 Jun;85(Pt 6):1401-1412
15166422
J Gen Virol. 2006 Jan;87(Pt 1):29-38
16361415
Cell. 1992 Oct 2;71(1):145-52
1339315
J Gen Virol. 2007 Jun;88(Pt 6):1656-1666
17485524
J Immunol. 1994 Jul 15;153(2):701-11
8021506
J Virol. 2001 Jan;75(2):850-6
11134298
Nucleic Acids Res. 1990 Jul 25;18(14):4285-6
2377486
J Virol. 1988 Oct;62(10):3772-8
3418784
Gene. 1989 Apr 15;77(1):61-8
2744488
J Exp Med. 2003 Feb 3;197(3):343-51
12566418
J Immunol. 2005 Mar 15;174(6):3608-16
15749898
Chem Biol. 1997 Feb;4(2):139-47
9190288
J Gen Virol. 2002 Aug;83(Pt 8):1977-1986
12124461
J Immunol. 1998 Aug 15;161(4):1997-2003
9712072
Virology. 1994 Oct;204(1):376-90
8091668
Proc Natl Acad Sci U S A. 1985 Aug;82(16):5300-4
3875097
J Exp Med. 2005 Mar 21;201(6):1007-18
15767367
Virology. 1993 Aug;195(2):732-44
8337842
J Biol Chem. 1993 Oct 15;268(29):22100-4
8408068
Peptides. 2002 May;23(5):823-34
12084512
Annu Rev Immunol. 1998;16:27-55
9597123
J Virol. 2005 Oct;79(20):12852-60
16188987
J Virol. 2004 Apr;78(7):3553-60
15016878
Annu Rev Immunol. 2003;21:377-423
12543935
J Gen Virol. 2006 May;87(Pt 5):1157-1161
16603516
Infect Immun. 2008 Mar;76(3):942-51
18086816
J Biol Chem. 2004 Aug 27;279(35):36570-8
15215253
J Gen Virol. 2002 Dec;83(Pt 12):2915-2931
12466468
J Virol. 1996 Sep;70(9):6479-85
8709286
Nature. 1983 Apr 7;302(5908):490-5
6835382
Virology. 1991 Feb;180(2):625-32
1989387